AbbVie Delivers on Promise of Higher Dividend and Stronger Stock Buybacks
AbbVie is joining the companies raising their shareholder rewards. The pharmaceutical products maker has announced how it will further commit to previously forecast moves.
AbbVie is joining the companies raising their shareholder rewards. The pharmaceutical products maker has announced how it will further commit to previously forecast moves.
Moleculin Biotech watched its shares climb on Thursday after the company announced a new breakthrough for cancer treatment.
AMAG Pharmaceuticals saw its shares skyrocket early on Thursday after the company announced that it received an FDA approval.
Tetraphase Pharmaceuticals saw its shares get cut in half on Wednesday after the firm provided an update on its late-stage clinical trial for the treatment of urinary tract infections.
With indiscriminate selling absolutely punishing some of the top large cap biotech stocks, one analyst says now is the time to buy.
The U.S. opioid crisis has cost $1 trillion in lost wages, productivity, and other expenditures since 2001. The cost is going to rise rapidly and it's doubtful that planned spending to battle the epidemic…
Catabasis Pharmaceuticals saw its shares skyrocket on Tuesday after the firm announced new results from its Duchene muscular dystrophy study with edasalonexent.
Clinical-stage biopharmaceutical company BioXel Therapeutics has filed with the SEC regarding its initial public offering.
Axovant Sciences saw its shares take a big step back to start out the week after the company announced that there would be some changes at the executive level.
The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The January 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Pharmacy retailer CVS beat estimates when it reported results Thursday morning. The company is using some of its tax windfall to raise its starting pay and improve other employee benefits.
White Americans are dying at higher rates from drug overdoses, alcohol, and suicide than citizens of other developed countries and than Americans of other racial/ethnic origins.
Four large-cap pharmaceutical leaders are rated Overweight at JPMorgan, and all make sense for growth accounts looking for some safety and income.
Theravance Biopharma shares made a solid gain on Wednesday after the company announced a global collaboration with Janssen Biotech.